Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children (Q43626562)

25 November 2017

Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children (English)

1 reference

25 November 2017

1 reference

Human metapneumovirus

object named as

human metapneumovirus

1 reference

Karl G Nicholson

1

1 reference

25 November 2017

Teresa McNally

2

1 reference

25 November 2017

Michael Silverman

3

1 reference

25 November 2017

Paul Simons

4

1 reference

25 November 2017

Joanne D Stockton

5

1 reference

25 November 2017

Maria C Zambon

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

25 February 2005

1 reference

25 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

25 November 2017

24

1 reference

25 November 2017

102-108

1 reference

25 November 2017

1

1 reference

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Respiratory syncytial virus or influenza?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Characterization of human metapneumoviruses isolated from patients in North America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Presence of the new human metapneumovirus in French children with bronchiolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Children with respiratory disease associated with metapneumovirus in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Human metapneumovirus infections in hospitalized children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Influenza and the rates of hospitalization for respiratory disease among infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Respiratory syncytial virus infection in young hospitalized children. Identification of risk patients and prevention of nosocomial spread by rapid diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Incidence of respiratory syncytial virus-positive hospitalizations in Germany.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

The incidence of influenza-associated hospitalizations in children in Germany.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Influenza-A infection in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Influenza A and B virus infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Influenza virus infections in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Impact of Influenza Virus Infection as a Cause of Pediatric Hospitalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Protection of infants from infection with influenza A virus by transplacentally acquired antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Clinical signs and symptoms predicting influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.02.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.02.004

1 reference

25 November 2017

1 reference